| Holmlin, Erik (Exiqon 200807– CCO before BD Diagnastics before GeneOhm co-founder in 2001) |
Chief Business Officer (CBO) |
Qiagen (Group) |
Denmark |
| Holsboer, Florian (MPI of Psychiatry + Neuronova Pharmaceuticals AG founder) |
Company Founder |
Max Planck Society for the Advancement of Science |
Germany |
| Holsether, Svein Tore (Yara 201509– CEO) |
Chief Executive Officer (CEO) |
Yara (Group) |
Norway |
| Holst, Otto (Protectimmun 200808 Founder) |
Company Founder |
Protectimmun GmbH |
Germany |
| Holstein, Jens (MorphoSys 201105–202012 CFO before Fresenius Kabi RESIGNED 12/20) |
Chief Financial Officer (CFO) |
MorphoSys (Group) |
Germany |
| Holtermüller, Siegbert (Olympus 201605 Managing Director at Olympus in Germany) |
Managing Director |
Olympus (Group) |
Germany |
| Holtkamp, Jens (Pulsar Photonics GmbH 201309– Managing Director + Co-Founder) |
Managing Director |
Pulsar Photonics GmbH |
Germany |
| Holtmann, Kai (Mevis 200904 Corporate Communication) |
Public Relations Manager / Investor Relations Manager |
Varian Medical Systems (Group) |
Germany |
| Holtorf, Marc L. (Pinsent Masons 202005 Partner + Head of IP + Life Sciences Germany) |
Attorney / Lawyer |
Pinsent Masons (Group) |
Germany |
| Holtz, Tina (Inveox GmbH 201908 Head of Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Inveox (Group) |
Germany |
| Holzammer, Rüdiger (Concord Equity Research 200809 Analyst) |
Analyst (Financial / Industry) |
Concord Equity Research |
Germany |
| Holzapfel, Oliver (Ritter GmbH 200704–) |
Sales Manager / Marketing Manager |
Ritter GmbH |
Germany |
| Holzmeister, Johannes (Dinaqor 202009 CEO + Co-Founder + Cardiorentis AG 201409 CEO + CMO) |
Chief Executive Officer (CEO) |
Dinaqor (Group) |
Switzerland |
| Holzäpfel, Dagmar (PP Wealth GmbH 201311 Managing Director) |
Managing Director |
PP Wealth GmbH |
Germany |
| Hombach, Michael (Univ Zürich 201106 Institute of Medical Microbiology) |
n. a. |
|
|
| Hombeck, Torsten (Promethera 201606 CCO before Cytonet + Agennix + GPC + Beiersdorf) |
Chief Commercial Officer (CCO) |
Promethera (Group) |
Belgium |
| Homberg, Peter (Dentons/Salans 201211 Partner Ffm before Raupach & Wollter-Elmendorff + Jones Day + Roche) |
Attorney / Lawyer |
Dentons (Group) |
Germany |
| Honig, Peter (Pfizer 202007 SVP Global Regulatory Affairs) |
Regulatory Affairs Manager |
Pfizer (Group) |
United States (USA) |
| Honisch, Christiane (Eppendorf 2018– Head Global Business Intelligence + Developm before Illumina + Roche + Sequenom) |
Business Development Manager / Strategy Manager |
Eppendorf (Group) |
Germany |
| Hood, Leroy (Lee) (Institute for Systems Biology) |
Professor |
Institute for Systems Biology (ISB) (Seattle) |
United States (USA) |
| Hooftman, Leon (Polyphor 201503– CMO before Synthon BV + Chroma Therapeutics Ltd + Celltech + Roche) |
Chief Medical Officer (CMO) |
Polyphor Ltd. (SIX: POLN) |
Switzerland |
| Hoogenboom, Bart (Univ College London 201909 Prof of Biophysics at London Centre for Nanotechnology) |
Professor |
University College London (UCL) |
United Kingdom (GB) |
| Hoogstraate, Janet (Valneva 201812 Chairman of Valneva Sweden AB) |
Board member |
Valneva (Group) |
Sweden |
| Hopf, Carsten (Hochschule Mannheim 201107 Professor + Head ZAFH-ABIMAS) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Hochschule Mannheim (Mannheim University of Applied Sciences, MUAS) |
Germany |
| Hopfgartner, Gérard (Univ Geneva 201003 Professor) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
| Hopfner, Rob (Nan Fung 201801 at Pivotal Bioventure Partners) |
Investment Manager |
Nan Fung (Group) |
United States (USA) |
| Hopkins, Andrew (Ex Scientia 201604 CEO) |
Chief Executive Officer (CEO) |
Exscientia (Group) |
United Kingdom (GB) |
| Hopkins, Barry (Rave LLC 201904 CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
| Hopkinson, Craig (Alkermes 201911 CMO + SVP Medicines Developm + Medical Affairs) |
Chief Medical Officer (CMO) |
Alkermes (Group) |
Ireland, Republic of |
| Hopp, Daniel (DAH Beteiligungs GmbH) |
n. a. |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Hopp, Dietmar (SAP) |
n. a. |
SAP (Group) |
Germany |
| Hoppe, Erik (Bioventure Consulting GmbH 201110 Managing Director) |
Managing Director |
Bioventure Consulting GmbH |
Germany |
| Hoppe, Wolfgang (AdVita Lifescience GmbH 201905– Managing Director) |
Managing Director |
Relief Therapeutics (Group) |
Germany |
| Hoppenot, Hervé (Incyte 201401– CEO before Novartis President Oncology) |
Chief Executive Officer (CEO) |
Incyte Corporation (Group) |
United States (USA) |
| Horak, Ivan (Symphogen 201405 CSO + CMO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Servier (Group) |
Denmark |
| Horch, Frank (Hamburg (govt) 201404 Senator für Wirtschaft, Verkehr + Innovation) |
Minister |
Hamburg (govt region) |
Germany |
| Horlacher, Reinhold (Trenzyme GmbH 2010– Managing Director + Founder) |
Managing Director |
Trenzyme (Group) |
Germany |
| Horland, Reyk (TissUse GmbH 201706 VP Business Development) |
Business Development Manager / Strategy Manager |
TissUse GmbH |
|
| Horn, Friedemann (Univ Leipzig 201602 Professor at Faculty of Medicine + Co-Founder Ribolution Health GmbH) |
n. a. |
|
|
| Horn, Marc (Merck (DE) 201604– Head Biopharma Business China before CFO Eastern Asia before Bayer + Lanxess) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Horneff, Friedel (Bio-Rad Laboratories GmbH 200803 Group Manager Life Science Central Europe) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
Germany |
| Hornemann, Thorsten (Lipidon 201808 CEO) |
Chief Executive Officer (CEO) |
Lipidon AG (Lipidon Analytics) |
Switzerland |
| Horning, Sandra (Roche 201401–201912 CMO + Head Global Product Development joined 2009 RETIRED 12/19) |
Chief Medical Officer (CMO) |
Roche (Group) |
Switzerland |
| Horns, Torsten (Cytolon 201210– before Epigenomics) |
Business Development Manager / Strategy Manager |
Cytolon AG |
Germany |
| Hornshaw, Martin (Thermo Fisher 201106 LCMS Marketing Manager Europe) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Hornstein, Jörg (AC Immune 201701– CFO before Theo Müller Group + Merck KGaA) |
Chief Financial Officer (CFO) |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Horst, Jens-Peter (Univ Göttingen 201009 Managing Director MBM ScienceBridge GmbH |
Managing Director |
University of Göttingen (Georg August University) |
Germany |
| Horstmann, Rolf (Leibniz-Gemeinschaft 200912 Chairman Bernhard Nocht Institute) |
n. a. |
Leibniz-Gemeinschaft |
Germany |
| Horvath, Diana (Two Blades Foundation 201205 COO) |
Chief Operating Officer (COO) |
Two Blades Foundation (2Blades) |
United States (USA) |
| Hosang, Markus (BioMedPartners 201108 General Partner) |
General Partner (venture partner) |
BioMedPartners (Group) |
Switzerland |
| Hothum, Mathias (Hopp Group 201304 Managing Director of Dievini Hopp Bio Tech Holding) |
Managing Director |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Houlton, Scott (MLM Medical Labs 202102– CEO before Clinical Supplies Management + Catalent + Aptuit + Quintiles) |
Chief Executive Officer (CEO) |
MLM Medical Labs (Group) |
Germany |
| Houston, John G. (Arvinas 201709– CEO joined 201701 as President RnD + CSO before over 28 years at BMS) |
Chief Executive Officer (CEO) |
Arvinas (Group) |
United States (USA) |
| Hove, Anders |
n. a. |
Bellevue (Group) |
Switzerland |
| Howaldt, Michael (Boehringer 201402 VP Biopharma Operations USA + Head of Fremont Site) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
United States (USA) |
| Howd, Adrian (Malin Corp 201508– Chief Investment Officer before CEO before Evotec) |
Investment Manager |
Evotec (Group) |
Germany |
| Howitz, Steffen (GeSiM 200604 Managing Director) |
Managing Director |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
| Hoyer, Olaf (Quantifoil Instruments 200702 Managing Director) |
Managing Director |
Quantifoil Instruments GmbH |
Germany |
| Hoyer, Werner (EU (govt) 201512 Group President of EIB) |
President/Director/Head Business Group/Unit/Division |
EU (govt) |
Luxembourg |
| Hrabé de Angelis, Martin (Helmholtz 201011 Helmholtz Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hrosch, Wolfgang (InProcess Instruments 1997– founder + Managing Director before LaserSpec Anayltik GmbH + Finnigan MAT) |
Managing Director |
InProcess Instruments Gesellschaft für Prozessanalytik mbH (IPI) |
Germany |
| Hrubý, Jan (DataApex 201204 General Manager) |
General Manager (management) |
DataApex (CZ) |
Czech Republic |
| Hsia, Eric (TransLink Capital 201809 Managing Director) |
Managing Director |
TransLink Capital (US) |
United States (USA) |
| Huang, Keith (Schauenburg 201911– Regional Manager Asia Pacific at Markes before Agilent) |
Regional manager |
Schauenburg (Group) |
China |
| Huang, Rani (RayBiotech 201408 COO + Co-founder) |
Chief Operating Officer (COO) |
RayBiotech Inc. |
United States (USA) |
| Huang, Song (Epithelix 201207 CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Epithelix Sàrl |
Switzerland |
| Huang, Yingying (Thermo Fisher 200810 Strategic Marketing Specialist Metabolism and Metabolomics group) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Hubbard, John (Pfizer 201312 SVP + Global Head of Development Operations) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Hubbell, Jeffrey A. (Anokion 201701 Chairman + CSO + Academic Founder + Prof at Univ Chicago + before at EPFL) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Anokion (Group) |
Switzerland |
| Huber, Andreas (Bayern (Govt) 201310 Senior Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Huber, Caroline (Tecan 201211 Senior Market Manager) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Huber, Christian (Univ Salzburg 201310 Professor + Head of CD Lab for Biosimilar Characterization) |
Professor |
University of Salzburg |
Austria |
| Huber, Christoph (CI3 Cluster 201307 Board Member of CI3 e.V.) |
n. a. |
Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.) |
Germany |
| Huber, Fritz (LipoFIT GmbH 201204 Managing Director + Co-founder) |
Managing Director |
Numares (Group) |
Germany |
| Huber, Hans (Biomay 201505 COO) |
Chief Operating Officer (COO) |
Biomay AG |
Austria |
| Huber, Jutta (Eurofins 201405 Managing Director Eurofins Genomics GmbH before MWG Biotech) |
Managing Director |
Eurofins (Group) |
Germany |
| Huber, Lukas (Medical Univ Innsbruck 201211 Professor + Director of the Biocenter) |
Professor |
Medical University Innsbruck (MUI) |
Austria |
| Huber, Mario (PharmaMar 201612– Managing Director of PharmaMar Austria before Quintiles) |
Managing Director |
PharmaMar (AT) |
Austria |
| Huber, Martin (Quantapore 201406 CEO + Founder before Ion Torrent) |
Chief Executive Officer (CEO) |
Quantapore Inc. |
United States (USA) |
| Huber, Robert (Univ Duisburg-Essen 201004 Professor ZMB before Max Planck Institute for Biochemistry, Nobel Laureate) |
Professor |
University of Duisburg-Essen |
Germany |
| Huber, Roman (Bayern Kapital 200612 Managing Director) |
Managing Director |
Bavaria (govt region) |
Germany |
| Huber, Walter (Merck 200601) |
n. a. |
Merck (DE) (Group) |
Germany |
| Huber-Saffer, Peter (Chiesi 201410 Business Development Manager at Chiesi GmbH) |
Business Development Manager / Strategy Manager |
Chiesi (Group) |
Germany |
| Huc, Jean-Francois (BioAmber 201207 CEO) |
Chief Executive Officer (CEO) |
BioAmber (Group) |
United States (USA) |
| Huchler, Roland (InnoCyte GmbH 201211 Managing Director + Founder) |
Managing Director |
InnoCyte GmbH |
Germany |
| Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Huebscher, Karen (Solvias 201403– CEO before Novartis) |
Chief Executive Officer (CEO) |
Solvias (Group) |
Switzerland |
| Huels, Christoph (Protagen 200704 CEO) |
Chief Executive Officer (CEO) |
Oncimmune (Group) |
Germany |
| Huelso, Gerd (Bruker 201310 Managing Director at Bruker Daltonik GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Huenges, Martin (Maiwald Patentanwalts GmbH 200809 Munich) |
n. a. |
Maiwald Patentanwalts GmbH (Munich) |
Germany |
| Hufnagel, Lars (Bruker 201912 VP + General Manager of Luxendo Business) |
General Manager (management) |
Bruker (Group) |
Germany |
| Hufnagel, Peter (Bruker 200712 Bruker Daltonik GmbH Project Manager ProteinScape) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Hug, Peter (Roche Pharma Partnering 200511) |
n. a. |
Roche (Group) |
Switzerland |
| Hughes, Owen (MPM Capitap 201710 Managing Director + Cullinan Oncology 201710– CEO before Intarcia + 16y at Wall Street) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
| Hughes, Thomas E. (Tom) (Navitor Pharmaceuticals 202002 CEO before Zafgen 2008–2017 before Novartis) |
Chief Executive Officer (CEO) |
Navitor Pharmaceuticals Inc. |
United States (USA) |
| Huhle, Doreen (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Huland, Edith (Immunservice GmbH 201205 Managing Director) |
Managing Director |
Immunservice GmbH |
Germany |
| Hulot, Thierry (Merck (DE) 201310– Head of Global Manufacturing + Supply at Merck Serono joined Merck 1995) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Humbey, Olivier (Accovion 201412– Country Director France) |
Regional manager |
Clinipace (Group) |
France |
| Humer, Franz B. (Roche –2014 non-exec Chairman before CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 27 28 29 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
